1. TIME AND PLACE a) Time: Sep 18 th -21 st, 2012 b) Place: Four Points by Sheraton Taicang, Suzhou 2. ORGANIZATION

Transcription

1 The 10th International Pharmaceutical High Technology & Industrialization Development Summit will be elaborately held on Sep 18 th -21 st, 2012, at Suzhou, Taicang by China Pharmaceutical Technology Transfer Center, China Pharmaceutical Industry Technology Promotion Organization, which is a top platform to gather domestic and overseas new drug R&D resources, to promote advanced technology, key technology, and core technology of industrialization. With the support of Ministry of Science and Technology, Ministry of Health and State Food and Drug Administration, local government, etc, it has enjoyed good reputation at home and abroad.. At that time, there are nearly 50 top experts from domestic and overseas pharmaceutical field and officials from National Development and Reform Commission, Ministry of Science and Technology and State Food and Drug Administration to give us splendid reports around progress of new drug advanced technology at home and abroad, Chinese pharmaceutical industry and regulatory affair. Also, there are several top project-docking discussions. It is estimated that almost 500 delegates will attend this summit from domestic and overseas Pharmaceutical Corporation, new drug R&D institute, investment and financing institute, CRO and other related organizations. Detail agenda is below: 1. TIME AND PLACE a) Time: Sep 18 th -21 st, 2012 b) Place: Four Points by Sheraton Taicang, Suzhou 2. ORGANIZATION

2 3. AGENDA 8:30 17:30 Tuesday, September 18, 2012 Registration 8:30 12:00 Wednesday, September 19, 2012 Keynote Speech Strategies for pharmaceutical industry development and innovation of new drugs in China Prof. Guowei SANG Vice Chairman of the National People s Congress Chairman of the Chinese Pharmaceutical Association Academician of the Chinese Academy of Engineering To promote innovation and industrialization of new drugs by development of GRP in China Mr. Wei ZHANG Director of Department of Drug Registration, SFDA To promote industrialization of major new drug projects by strengthening the dominant position of enterprises in innovation Ministry of Science and Technology, China To master the core technologies and to enhance the independent abilities biomedicine industry in China Department of High-Tech Industry, National Development and Reform Commission Open innovation and technology transfer of significant drug by multi-national pharmaceutical enterprises Speaker from Eli Lilly EU and US regulatory requirement for biosimilars Dr. Zak Huang Director of Worldwide Regulatory Affairs, Merck (MSD) 12:00 13:15 Lunch

3 Symposium 1 Technological forefront of new chemical drugs R&D 13:30 15:00 Technological forefront in the discovery of leading compounds and new drug targets Dr. Jingkang SHEN Director of the Chinese Academy of Sciences, Shanghai Pharmaceutical Institute Application of asymmetric reaction in the synthesize of chiral drugs Prof. Fen er CHEN Department of Chemistry, the Fudan University R&D of new drugs for the targeted therapy of neurodegenerative disease Dr. Xiangping QIAN CEO, Suzhou NeuPharma Co., Ltd. 15:00 15:30 15:30 16:30 Two speakers are going to be confirmed 16:30 17:30 Symposium 2 Technological forefront and internationalization of TCM/natural drugs R&D 13:30 15:00 Quality evaluation of innovative drugs R&D from TCM Prof. Ruichao LIN Director of Institute for Control of Chinese Traditional Medicine and Ethnic Medicine, National Institutes for food and drug Control (NIFDC) Discovery and R&D of new drugs based on the concept of natural pharmacy Prof. Renbing SHI Vice dean of Chinese Materia Medica School, Beijing University of Chinese Medicine New technologies and new trends in the new drug R&D of TCM internationalization Prof. Yitao WANG

4 Institute of Chinese Medicine Science, the University of Macau 15:00 15:30 15:30 16:30 Innovative R&D of TCM Prof. Hongxi XU Vice dean of Chinese Materia Medica School, Shanghai University of Traditional Chinese Medicine Internationalization of quality standards of Chinese medicine---a case analysis of Diao Xinxuekang Dr. Jianxin JI Director of Institute of Metaria Medica, Diao Group 16:30 17:30 Symposium 3 Technological forefront of Biopharmaceutical R&D 13:30 15:00 The trends and progress of R&D on Biotechnological drugs Mr. Xinliang SHEN Deputy General Manager, China National Biotec Group Research of human monoclonal antibody targeting therapy of tumor Prof. Zhihua YANG Cancer Instisute, Chinese Academy of Medical Sciences The establishment and application of key technologies research platform for nucleic acid drug Prof. Shengqi WANG Institute of Radiation Medicine, Academy of Military Medical Sciences 15:00 15:30 15:30 16:30 Complex structural analysis of recombinant protein drugs Prof. Kaihua WEI Director of Peptidomics Lab, the Beijing Proteomics Research Center

5 Therapeutic vaccines for cervical cancer Taiwan ShengBao Biotechnology Co., Ltd. 16:30 17:30 Thursday, September 20, 2012 Symposium 4 Technology forefront of Translational Medicine and new drug R&D 8:30 10:00 The current status and the prospect of antibody drugs for tumor immunotherapy Prof. Zonghai LI Shanghai Cancer Institute R&D of one new therapy for cancer based on activated dendritic cells Libor Taborsky CEO, SOTIO Medical Research Co., Ltd. Czech Republic Effective screening of biomarkers by omics technology with high throughput Dr. Huasheng XIAO Managing Director of Shanghai Biochip Co., Ltd. 10:00 10:30 10:30 11:30 Identification of biomarkers in the R&D of new drug Dr. Danyi WEN Senior Vice President, Shanghai ChemPartner Co., Ltd. One speaker to be confirmed 11:30 12:00 12:00 13:15 Lunch Symposium 5 Technological forefront of Manufacture and the quality improvement of drug (The co- organizers: Shanghai Henlius Biotech Co. Ltd., Beijing Canny Consulting

6 Inc.) 8:30 10:00 The quality standards of the recombinant protein drug during "The 12th Five Years-Plan Ms. Qi SHEN Director of Department of Biological Products, the National Institutes for Food and Drug Control The quality standards management of drug based on new pharmacopoeia Mr. Ping WANG Deputy Secretary-General,Pharmacopoeia Commission of China Drug safety Regulatory of biological products under the new GMP Speaker to be confirmed Center for Certification of Drug, the State Food and Drug Administration 10:00 10:30 10:30 11:30 New GMP for certification and certification points from GMP of Europe and the United States Mr. Pengcheng KANG Chairman of the board, Beijing Canny Consulting Inc. The international application trend of single use manufacturing system Mr. Jerold Martin Chairman,The Bio-Process Systems Alliance 11:30 12:00 12:00 13:15 Lunch 4. Project cooperation communicating and negotiating 1) project referrals and road shows (domestic and overseas) Trough live project referrals, road shows, project introductions, materials, project releasing, negotiations and other ways; practical, innovative and mature new drug technology projects are screened to promote new drug technology transfer and commercialization cooperation at home and abroad. 2) Special docking activities of regional medicine industry

7 During this summit, project docking will carry out for local bio-pharmaceutical industry development, corporate technology innovation requirements, technology transfer or cooperation requirement of new drug R&D organization. 3) Project introduction meeting for Bio-pharmaceutical Park During this summit, some docking activities will be hold for international technology transfer projects, talent returnees, transnational pharmaceutical companies and Bio-pharmaceutical Parks, which can meet the investment demand of Bio-pharmaceutical Parks, incubators, industrialization base. (Hot and limited!) 5. TARGET AUDIENCE 1) Domestic and overseas pharmaceuticals groups, drug manufacturing enterprises, technology managers who are responsible for R&D and technology 2) Domestic and overseas research institutes, new drug R&D institutes, national key laboratories, managers and technical staff from universities, drug departments, medicine department, biology department 3) Executives and project leaders from new drug R&D enterprises and technology service institutes at home and abroad 4) Executives and project leaders from new drug R&D, investment, technology transfer and industrialization promotion institutes, which include Pharmaceutical Industry Park, incubator, investment organization, company, medical institutes, technology agency, etc. 6. COOPERATION OPPORTUNITIES 1) Speech and Exchange There are special chances at this summit for drug manufacturing enterprises, R&D institutes, CRO institutes, etc. Welcome to recommend appropriate topics and experts related our summit. 2) Project referral and releasing There are live project referrals for optimized projects, and international project is preferred (approximately 10-15mins). This is a book of project compilation for participants about project transfer and requirement. 3) Display platform Platform for product, technology, service is provided; both parties can discuss the cooperation issue. 7. Links about Suzhou

8 PAYMENT 3200 RMB or $500 per person, which includes registration, conference meal, material and travel. 9. CONTACT US 1. China Pharmaceutical Technology Transfer Center (CPTTC) Beijing Add: Tower A, 20 th floor, Top Building, No.3 Haidian Street, Zhangguancun, Beijing, China Tel: ext858 Fax: Contact person: Hui Zhang Website: 2. Shanghai branch center Add:Fengxian Bio-tech Park, No. 588 Jinhai Road, Shanghai Tel: Fax: Contact person: Lei Peng

9 The 10th International Pharmaceutical Advanced Technology & Industrialization Development Summit Registration Form Company Add Mobile No. Postcode Contact person Position Tel/Fax Participants Name Gender Department and Position Mobile No Hotel information: AICANG_PROP_OVERVIEW&propertyID=3377&language=en_US&localeCode=en_US Please us this form to forum@pharmtec.org.cn Website: